Anvisa's New Regulation Of Products Containing Cannabis

Author:Mr Lior Pinsky and Renata Fialho De Oliveira
Profession:Veirano e Advogados Associados

On December 3, 2019 the National Health Surveillance Agency (ANVISA) approved the Collegiate Board of Officers Resolution which regulates the manufacture, prescription, import and commercialization of products containing Cannabis sativa and sets forth the rules for monitoring and surveillance of products containing referred active ingredient for medicinal purposes.

Products containing cannabis will only be allowed for sale upon presentation of a special medical prescription which must be retained by the pharmacy or drugstore.

The regulation will be reviewed within 3 years.

The approved regulation will be published in the...

To continue reading